Chemotherapy-induced veno-occlusive disease of the liver.
Lee
A C
AC
Lau
Y L
YL
D000009:Abdominal Muscles; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003609:Dactinomycin / Q000009:adverse effects; D018240:Endodermal Sinus Tumor / Q000188:drug therapy; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D008297:Male; D019042:Muscle Neoplasms / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local; D014750:Vincristine / Q000009:adverse effects
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide